Article Details

CASI Pharmaceuticals Announces Full Year 2020 Financial Results

Retrieved on: 2021-03-30 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

CASI Pharmaceuticals Announces Full Year 2020 Financial Results. View article details on hiswai:

Excerpt

BI-1206 (Anti-FcyRIIB antibody) ... express CD38, and potentially better safety and best in class when compared to other CD38 monoclonal antibodies.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up